All posts in HEMATOLOGY ONCOLOGY SERIES

HEMATO-ONCOLOGY PART-42 Question: Dr. Chiragbhai, thank you for explaining in last part about primary myelofibrosis, especially regarding its specific complications, need to avoid splenectomy, and new targeted treatment options like ruxolitinib, everolimus, and curative treatment with stem cell transplant. What is the next disorder we will be talking about. Ans: We have covered all the […]